• Text size
  • Send this article to a friend
  • Print this article

UK approval of cancer drug boosts ProStrakan

Prostrakan, the Borders-based specialist drugs firm, yesterday said it had received earlier-than-expected approval in the UK for its cancer drug Abstral.

Custom byline text: 
Mark Smith

Prostrakan, the Borders-based specialist drugs firm, yesterday said it had received earlier-than-expected approval in the UK for its cancer drug Abstral.